MorphoSys to Present Data on Proprietary Programs at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MorphoSys to Present Data on Proprietary Programs at American Society of Clinical Oncology Annual Meeting

MARTINSRIED / MUNICH, Germany, May 13, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced the publication of three MorphoSys abstracts which were submitted to the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting to take place from May 29 to June 2 in Chicago, Illinois. The abstracts include pre-clinical and first clinical data on the Company's proprietary drug candidate MOR202 from a Phase 1/2a study in patients with multiple myeloma and updated clinical data for the MOR208 program.

"We are delighted to publish a substantial package of clinical and preclinical data at the preeminent conference on clinical oncology. The data set provides additional insight into the progress of our lead cancer compounds MOR208 and MOR202," commented Dr. Arndt Schottelius, Chief Development Officer of MorphoSys AG. "For MOR202, we are in particular looking forward to presenting not only safety data but also first efficacy data from the Phase 1/2a study in multiple myeloma."

List of abstracts:

Abstract #8574

A phase 1/2a study of the human anti-CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma (rrMM).

The poster presentation will include the in the abstract described safety results and additional first efficacy results. The poster presentation will take place on Sunday, May 31, 8:00 AM - 11:30 AM CDT, as part of the Lymphoma and Plasma Cell Disorders track.

Abstract #8588

Effect of IMiD compounds on CD38 expression on multiple myeloma cells: MOR202, a human CD38 antibody in combination with pomalidomide.

The poster presentation will take place on Sunday, May 31, 8:00 AM - 11:30 AM CDT, as part of the Lymphoma and Plasma Cell Disorders track.

Abstract #8500

Phase 2a study of single-agent MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL).

The oral presentation will take place Monday, Jun 1, 9:45 AM - 9:57 AM CDT, as part of the Lymphoma and Plasma Cell Disorders track.

Additionally, MorphoSys's partners will present data for several HuCAL antibodies, which are currently in clinical development:

Abstract #3004

A phase I study of PF-05082566 (anti-4-1BB) + rituximab in patients with CD20+ NHL.

Abstract #590

Phase 1 study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC).

Abstract #7508

Final results of phase 1b of tarextumab (TRXT, OMP-59R5, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC).

The full abstracts can be accessed online at http://abstracts.asco.org/ .

About MorphoSys: MorphoSys developed HuCAL, the most successful antibody library technology in the pharmaceutical industry. By successfully applying this and other patented technologies, MorphoSys has become a leader in the field of therapeutic antibodies, one of the fastest-growing drug classes in human healthcare.

Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 90 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. With its ongoing commitment to new antibody technology and drug development, MorphoSys is focused on making the healthcare products of tomorrow. MorphoSys is listed on the Frankfurt Stock Exchange under the symbol MOR. For regular updates about MorphoSys, visit http://www.morphosys.com

HuCAL ® , HuCAL GOLD ® , HuCAL PLATINUM ® , CysDisplay ® , RapMAT ® , arYla ® and Ylanthia ® and 100 billion high potentials ® are registered trademarks of MorphoSys AG.

Slonomics ® is a registered trademark of Sloning BioTechnology GmbH, a subsidiary of MorphoSys AG.

This communication contains certain forward-looking statements concerning the MorphoSys group of companies. The forward-looking statements contained herein represent the judgment of MorphoSys as of the date of this release and involve risks and uncertainties. Should actual conditions differ from the Company's assumptions, actual results and actions may differ from those anticipated. MorphoSys does not intend to update any of these forward-looking statements as far as the wording of the relevant press release is concerned.

For more information, please contact:

MorphoSys AG Dr. Claudia Gutjahr-Löser Head of Corporate Communications & IR

Mario Brkulj Associate Director Corporate Communications & IR

Alexandra Goller Manager Corporate Communications & IR

Jessica Rush Manager Corporate Communications & IR

Tel: +49 (0) 89 / 899 27-404 investors@morphosys.com

Media Release http://hugin.info/130295/R/1921618/688764.pdf

HUG#1921618

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 6

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 109

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 84

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 129

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 92

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 78

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 135

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 20

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 74

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 128

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating Greenlight Capital Re's Q4 and Annual Results

Updated Category News Views 139

Greenlight Capital Re, Ltd. Plans Future Financial Release Greenlight Capital Re, Ltd. (NASDAQ: GLRE), a leading multiline property and casualty insurer and reinsurer, has announced its schedule for releasing financial results for the fourth quarter and full year, which ended on December 31, 2024. The company is set to disclose these important results after the market...

Continue Reading
Integral Ad Science Holdings Faces Shareholder Lawsuit Insights

Updated Category News Views 125

Integral Ad Science's Shareholder Alert Integral Ad Science Holding Corp. (NASDAQ: IAS) is currently grappling with a significant legal challenge. A class action lawsuit has been filed against the company, alerting shareholders of their rights and options. Investors linked to the company should be aware of these developments as they navigate their positions in the market....

Continue Reading
Corcoran Expands Internationally with New Franchise Launch

Updated Category News Views 145

Corcoran Launches New Franchise in Mexico Corcoran Group LLC has taken a significant step in its expansion strategy by announcing the launch of its first franchise in Mexico, named Corcoran The Baja Real Estate Co. Led by Blake Harrington, this new brokerage is set to serve clients in the vibrant area surrounding Cabo San Lucas. This strategic move underscores Corcoran's...

Continue Reading
Titan Mining Announces Details for Upcoming AGM Meeting

Updated Category News Views 263

Titan Mining Corporation's Upcoming Annual General Meeting Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) is set to hold its annual general meeting soon, a much-anticipated event for shareholders and stakeholders alike. The date is indeed significant as it marks an opportunity for the company to engage directly with its investors. Meeting Details and Importance The...

Continue Reading
Investing in EQT: A 20-Year Journey of Growth and Returns

Updated Category News Views 182

Understanding EQT Corporation's Investment Landscape EQT Corporation (NYSE: EQT) has shown substantial growth in the investment landscape over the past two decades. Over this period, EQT has consistently outperformed the market by 10.28% on an annualized basis, resulting in an impressive average annual return of 18.48%. This growth has contributed to EQT's current market...

Continue Reading